Clinical trial
Comparison of Tamsulosin and Silodosin on Pupil Size and Choroidal Thickness in Patients With Benign Prostatic Hyperplasia
NCT07743060 is registered in ClinicalTrials.gov with Mohsen Pourazizi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Tamsulosin and Silodosin on Pupil Size and Choroidal Thickness in Patients With Benign Prostatic Hyperplasia
- Lead sponsor
- Mohsen Pourazizi
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- April 30, 2027
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostatic hyperplasia, choroid, iris disease, silodosin, tamsulosin, tomography, optical coherence